PDL BioPharma News | finanzen.ch

Kurse + Charts + Realtime	News + Analysen	Fundamental	Unternehmen	zugeh. Wertpapiere	Aktion
Kurs + Chart	Chart (gross)	News + Adhoc	Bilanz/GuV	Termine	Strukturierte Produkte	Portfolio
Times + Sales	Chartvergleich	Analysen	Schätzungen	Profil	Trading-Depot	Watchlist
Börsenplätze	Realtime Push	Kursziele	Dividende/GV
Historisch			Analysen

Kurse + Charts + Realtime

News + Analysen

Fundamental

Unternehmen

zugeh. Wertpapiere

Aktion

Kurs + Chart

Chart (gross)

News + Adhoc

Bilanz/GuV

Termine

Strukturierte Produkte

Portfolio

Times + Sales

Chartvergleich

Analysen

Schätzungen

Profil

Trading-Depot

Watchlist

Börsenplätze

Realtime Push

Kursziele

Dividende/GV

Historisch

Analysen

23.02.15	PDL BioPharma Results Miss Estimates; Stock Down 7% (RTTNews)
10.12.14	PDL BioPharma Provides Q4 Revenue Guidance (RTTNews)
14.11.14	PDL BioPharma Gets $30.3 Mln To Conclude Revenue Interest Agreement With AxoGen (RTTNews)
11.11.14	PDL BioPharma Q3 Profit Surges (RTTNews)
10.11.14	PDL BioPharma Q3 Profit Tops Estimate (RTTNews)
23.09.14	PDL BioPharma Disputes Allegations In Class Action Lawsuit (RTTNews)
09.09.14	PDL BioPharma Sees Q3 Revenue Above Consensus; Stock Up - Quick Facts (RTTNews)
19.08.14	PDL BioPharma Q2 Profit Down, But Tops View, Shares Up - Update (RTTNews)
19.08.14	PDL BioPharma Q2 Profit Beats Estimate (RTTNews)
13.05.14	PDL BioPharma Q1 Profit Miss View, But Revenues Top (RTTNews)
12.05.14	PDL BioPharma Q1 Profit Rises - Quick Facts (RTTNews)
11.03.14	PDL BioPharma Sees Q1 Revenue Above Street - Quick Facts (RTTNews)
04.03.14	PDL BioPharma Q4 Results Miss Estimates (RTTNews)
03.03.14	PDL BioPharma Q4 Profit Rises - Quick Facts (RTTNews)
11.12.13	AVNR's PRIME Flops, BG Medicine Tastes Sweet, CYTR Awaits Data, ENTA Shines (RTTNews)
10.12.13	PDL BioPharma Issues Q4 Revenue Guidance - Quick Facts (RTTNews)
22.10.13	Oxygen Bio Breathes Anew, KERX Gets FDA Date, Rockwell Continues To Rock (RTTNews)
21.10.13	Depomed Sells Royalty & Milestone Payments In Type 2 Diabetes To PDL BioPharma (RTTNews)
21.10.13	PDL BioPharma Acquires Portfolio of Diabetes Royalty Rights and Milestones from Depomed (PR Newswire)
17.10.13	Technical Study: Amgen Inc., Questcor Pharmaceuticals Inc., PDL BioPharma Inc., and BioCryst Pharma Inc. (PR Newswire)
10.10.13	Stock Option Grants, FDA Agreements, Financing Transactions, Clinical Trial Updates, and New Appointments - Research Report on Aegerion, CTI, PDL, Halozyme, and Acorda (PR Newswire)
02.10.13	PDL BioPharma Provides $60 Million in Financing to LENSAR (PR Newswire)
20.09.13	Today's Research: Amgen Inc., BioCryst Pharmaceuticals Inc., PDL BioPharma Inc., and Questcor Pharmaceuticals Inc. (PR Newswire)
12.09.13	Biotech Firms Receive Orphan Drug Designations, Release Clinical Data, Achieve Goals, Enter Acquisitions & Forecast Revenues - Research Report on Aegerion, Oncolytics, Merrimack, Sangamo, and PDL (PR Newswire)
12.09.13	PDL BioPharma Completes Regular Quarterly Dividend Payment (PR Newswire)
11.09.13	PDL BioPharma to Present at the 4th Annual Credit Suisse Small/Mid Cap Conference (PR Newswire)
09.09.13	PDL BioPharma Sees Nearly $97 Mln Of Revenue In Q3 - Quick Facts (RTTNews)
09.09.13	PDL BioPharma Provides Third Quarter 2013 Revenue Guidance of $97 Million (PR Newswire)
04.09.13	PDL BioPharma Announces Conversion Rate Adjustments for Convertible Notes (PR Newswire)
15.08.13	Ongoing Clinical Trials, New Services, and Financial Results - Research Report on Celldex Therapeutics, Allscripts, Covance, PDL BioPharma, and BioScrip (PR Newswire)
14.08.13	Morning Research: BioCryst Pharma Inc., Questcor Pharma Inc., PDL BioPharma Inc., and Amgen Inc. (PR Newswire)
08.08.13	PDL BioPharma Q2 Profit Rises - Quick Facts (RTTNews)
08.08.13	PDL BioPharma Announces Second Quarter 2013 Financial Results (PR Newswire)
08.08.13	Earnings Watch For August 8 (MDRX, PCLN, DV, DF) (RTTNews)
05.08.13	Accretive Collaborations, Strengthened Management, and Earnings Release Schedules - Research Report on Seattle Genetics, Santarus, BioCryst, NPS, and PDL BioPharma (PR Newswire)
01.08.13	PDL BioPharma to Announce Second Quarter 2013 Financial Results on August 8, 2013 (PR Newswire)
26.09.07	Highland Capital Urges Sale of PDL BioPharma and Recommends Immediate Board and Management Changes (Businesswire)
14.03.05	Protein Design kann Markterwartungen erfüllen (n/a)
25.01.05	Protein Design Labs übernimmt ESP Pharma für 475 Mio. Dollar (n/a)
12.01.05	Protein Design Labs präzisiert Prognose für 2004 (n/a)

Aktien Top/Flop

SMI
SPI
SLI
SMIM
DAX
ESTOXX
Dow Jones
S&P 500
NASDAQ 100
Nikkei 225

Portfolioname Watchlistname
Portfolio
Name
Typ
Valor / ISIN
Börse
Anzahl
Aktueller Kurs
Kurszeit
Kaufpreis
Kaufdatum
Kaufwert	CHF
	Hinzufügen Speichern

Geberit	600.60	2.67 %	K V
Logitech Intl	73.94	1.62 %	K V
Kuehne+Nagel Int	190.20	1.30 %	K V
Swiss Re	147.75	0.96 %	K V
Swiss Life Hldg	827.00	0.83 %	K V
Nestle	85.03	-0.05 %	K V
UBS Group	27.39	-0.11 %	K V
CieFinRichemont	155.80	-0.13 %	K V
Roche Hldg G	257.40	-0.62 %	K V
Alcon	73.48	-7.22 %	K V

PDL BioPharma Aktie VALOR 2402661 / ISIN US69329Y1047

Nachrichten zu PDL BioPharma Inc.

Aktien Top/Flop

Meistgelesene Nachrichten